Proton energy optimization and reduction for intensity-modulated proton therapy

October 10, 2014 | Comments Off on Proton energy optimization and reduction for intensity-modulated proton therapy

Physics in Medicine and Biology 2014 October 8. [Epub ahead of print] Link Cao W, Lim G, Liao L, Ki Y, Jiang S, Li X, Li H, Suzuki K, Zhu…

Airways microbiota: Hidden Trojan horses in asbestos exposed individuals?

October 9, 2014 | Comments Off on Airways microbiota: Hidden Trojan horses in asbestos exposed individuals?

Medical Hypothese. 2014 September 19. [Epub ahead of print] Link Magouliotis DE, Taslopoulou VS, Molyvdas PA, Gourgoulianis KI, Jatzoglou C, Zarogiannis SG. Abstract Malignant pleura mesothelioma (MPM) is a rare…

Local and Systemic Therapies for Malignant Pleural Mesothelioma

October 8, 2014 | Comments Off on Local and Systemic Therapies for Malignant Pleural Mesothelioma

Current Treatment Options in Oncology. 2014 September 30. [Epub ahead of print] Link Gomez D, Tsao AS. Abstract Malignant pleural mesothelioma (MPM) is a challenging disease to treat with median…

Electron Microscopy Remains the Gold Standard for the Diagnosis of Epithelial Malignant Mesothelioma: A Case Study

October 7, 2014 | Comments Off on Electron Microscopy Remains the Gold Standard for the Diagnosis of Epithelial Malignant Mesothelioma: A Case Study

Ultrastructural Pathology. 2014 September 30. [Epub ahead of time] Link Oczypok EA, Oury TD. Abstract This is a case of idiopathic epithelial malignant mesothelioma in a 47-year-old mechanic. The advent…

Successful Combined Intratumoral Immunotherapy of Established Murine Mesotheliomas Requires B-Cell Involvement

October 6, 2014 | Comments Off on Successful Combined Intratumoral Immunotherapy of Established Murine Mesotheliomas Requires B-Cell Involvement

Journal of Interferon and Cytokine Research. 2014 September 26. [Epub ahead of print] Link Krishnan S, Bakker E, Lee C, Kissick HT, Ireland DJ, Beilharz MW. Abstract Combination immunotherapy has…

CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?

October 5, 2014 | Comments Off on CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?

Cancer Immunology, Immunotherapy : CII. 2014 September 19. [Epub ahead of print] [Link] Calabro L, Ceresoli GL, di Pietro A, Cutaia O, Morra A, Ibrahim R, Maio M. Abstract No…

A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

October 4, 2014 | Comments Off on A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

Trials. 2014 September 19 [Link] Gunatilake S, Brims FJ, Fogg C, Lawrie I, Maskell N, Forbes K, Rahman N, Morris S, Ogollah R, Gerry S, Peake M, Darlison L, Chauhan…

Malignant Pleural Mesothelioma: Visual Assessment by Using Pleural Pointillism at Diffusion-weighted MR Imaging

October 3, 2014 | Comments Off on Malignant Pleural Mesothelioma: Visual Assessment by Using Pleural Pointillism at Diffusion-weighted MR Imaging

Radiology. 2014 September 19. [Epub ahead of print] [Link] Coolen J, De Keyzer F, Nafteux P, De Wever W, Dooms C, Vansteenkiste J, Derweduwen A, Roebben I, Verbeken E, De…

Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients

October 2, 2014 | Comments Off on Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients

Clinical Lung Cancer. 2014 August 15 [Epub ahead of print] [Link] Powrozek T, Kowalski DM, Krawczyk P, Ramlau R, Kucharczyk T, Kalinka-Warzocha E, Knetki-Wroblewska M, Winiarczyk W, Krzahowski M, Milanowski…

An anti-mesothelin-monomethyl auristatin E conjugate with potent anti-tumor activity in ovarian, pancreatic and mesothelioma models

October 1, 2014 | Comments Off on An anti-mesothelin-monomethyl auristatin E conjugate with potent anti-tumor activity in ovarian, pancreatic and mesothelioma models

Molecular Cancer Therapeutics. 2014 September 23 [Epub ahead of print] [Link] Scales SJ, Gupta N, Pacheco G, Firestein R, French DM, Koeppen H, Rangell L, Barry-Hamilton V, Luis E, Chuh…

Categories